Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists

Details for Australian Patent Application No. 2001262257 (hide)

Owner Novartis AG

Inventors Nozulak, Joachim

Agent Davies Collison Cave

Pub. Number AU-B-2001262257

PCT Pub. Number WO01/85727

Priority 0010955 05.05.00 GB

Filing date 3 May 2001

Wipo publication date 20 November 2001

Acceptance publication date 4 November 2004

International Classifications

C07D 453/06 Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

A61K 031/439 - the ring forming part of a bridged ring system, e.g. quinuclidine

A61P 043/00 Drugs for specific purposes, not provided for in groups

Event Publications

4 November 2004 Application Accepted

  Published as AU-B-2001262257

3 March 2005 Standard Patent Sealed

4 January 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001262259

2001262256